Hrt Financial LP Hcw Biologics Inc. Transaction History

Hrt Financial LP

  • $12.8 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$0.42 - $0.7 $8,468 - $14,113
-20,162 Reduced 30.25%
46,497 $25,000
Q2 2024

Aug 12, 2024
SELL
$0.64 - $1.68 $4,130 - $10,842
-6,454 Reduced 8.83%
66,659 $43,000
Q1 2024

May 13, 2024
BUY
$1.1 - $1.77 $80,424 - $129,410
73,113 New
73,113 $127,000

Others Institutions Holding HCWB

# of Institutions
16
Shares Held
1.16M
Call Options Held
0
Put Options Held
0
View Full List

About HCW Biologics Inc.

HCWB Quotes by TradingView
  • Ticker HCWB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,833,100
  • Market Cap $151M
  • Description
  • HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...
More about HCWB
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email